Loading...
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
The new selective 5-HT2 receptor blocking agent ketanserin was given in a dose of 10 mg intravenously to 12 patients with essential hypertension. It caused a distinct fall in supine systemic arterial, right atrial, pulmonary artery, and pulmonary capillary "wedge" pressures. Cardiac output...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
1982
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1496107/ https://ncbi.nlm.nih.gov/pubmed/6800533 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|